RATIONALE: Dysfunction of executive neuropsychological performance, mediated by the prefrontal cortex, has been the central focus of recent attention deficit/ hyperkinetic disorder (AD-HKD) research. The role of other potential neuropsychological "risk factors", such as recognition memory, remains understudied. Further, the impact of methylphenidate (MPH) on key neuropsychological processes in AD-HKD remains poorly understood. OBJECTIVES: To compare the performance of boys with AD-HKD on a spatial working memory (SWM) task and on two non-working memory tasks [a simultaneous and delayed matching-to-sample task (DMtS) and a pattern-recognition task] with that of healthy boys, and to investigate the impact of acute and chronic MPH on performance of these tasks. METHODS: Baseline performance of 75 stimulant-naive boys with AD-HKD was compared with that of 70 healthy boys. The AD-HKD boys were then re-tested following the administration of acute and chronic challenges with MPH (0.3 mg/kg and 0.6 mg/kg) under randomised double-blind placebo controlled conditions. RESULTS: Compared with healthy boys, the AD-HKD boys demonstrated performance deficits on all neuropsychological tasks. A single dose of MPH restored performance on the DMtS task but had no impact on the SWM or pattern-recognition tasks. Chronic MPH administration did not alter performance on the SWM task but did improve performance on both the pattern-recognition and DMtS tasks. However, the acute restorative effect of MPH on DMtS diminished with repeated administration. CONCLUSIONS: Our results suggest that current conceptualisations of the neuropsychological basis of AD-HKD and the proposed therapeutic mechanisms of MPH require broadening.
RCT Entities:
RATIONALE: Dysfunction of executive neuropsychological performance, mediated by the prefrontal cortex, has been the central focus of recent attention deficit/ hyperkinetic disorder (AD-HKD) research. The role of other potential neuropsychological "risk factors", such as recognition memory, remains understudied. Further, the impact of methylphenidate (MPH) on key neuropsychological processes in AD-HKD remains poorly understood. OBJECTIVES: To compare the performance of boys with AD-HKD on a spatial working memory (SWM) task and on two non-working memory tasks [a simultaneous and delayed matching-to-sample task (DMtS) and a pattern-recognition task] with that of healthy boys, and to investigate the impact of acute and chronic MPH on performance of these tasks. METHODS: Baseline performance of 75 stimulant-naive boys with AD-HKD was compared with that of 70 healthy boys. The AD-HKDboys were then re-tested following the administration of acute and chronic challenges with MPH (0.3 mg/kg and 0.6 mg/kg) under randomised double-blind placebo controlled conditions. RESULTS: Compared with healthy boys, the AD-HKDboys demonstrated performance deficits on all neuropsychological tasks. A single dose of MPH restored performance on the DMtS task but had no impact on the SWM or pattern-recognition tasks. Chronic MPH administration did not alter performance on the SWM task but did improve performance on both the pattern-recognition and DMtS tasks. However, the acute restorative effect of MPH on DMtS diminished with repeated administration. CONCLUSIONS: Our results suggest that current conceptualisations of the neuropsychological basis of AD-HKD and the proposed therapeutic mechanisms of MPH require broadening.
Authors: R D Todd; E R Rasmussen; R J Neuman; W Reich; J J Hudziak; K K Bucholz; P A Madden; A Heath Journal: Am J Psychiatry Date: 2001-11 Impact factor: 18.112
Authors: John J Chelonis; Mark C Edwards; Eldon G Schulz; Ronald Baldwin; Donna J Blake; Alyssa Wenger; Merle G Paule Journal: Exp Clin Psychopharmacol Date: 2002-11 Impact factor: 3.157
Authors: Jesse S Rodriguez; Nicole R Zürcher; Thad Q Bartlett; Peter W Nathanielsz; Mark J Nijland Journal: J Neurosci Methods Date: 2011-01-27 Impact factor: 2.390
Authors: Robert M Bilder; Sandra K Loo; James J McGough; Fiona Whelan; Gerhard Hellemann; Catherine Sugar; Melissa Del'Homme; Alexandra Sturm; Jennifer Cowen; Grant Hanada; James T McCracken Journal: J Am Acad Child Adolesc Psychiatry Date: 2016-06-07 Impact factor: 8.829
Authors: Sarah A Morrow; Tanya Kaushik; Peter Zarevics; David Erlanger; Mark F Bear; Frederick E Munschauer; Ralph H B Benedict Journal: J Neurol Date: 2009-03-05 Impact factor: 4.849